resorufin has been researched along with furafylline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burke, MD; Mayer, RT; Thompson, S; Weaver, RJ; Wolf, CR | 1 |
| Bu, HZ; Knuth, K; Magis, L; Teitelbaum, P | 1 |
2 other study(ies) available for resorufin and furafylline
| Article | Year |
|---|---|
Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.
Topics: Adult; Alkylation; Animals; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP2B1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Isoenzymes; Male; Microsomes, Liver; Middle Aged; Oxazines; Oxidoreductases; Rats; Rats, Sprague-Dawley; Species Specificity; Substrate Specificity; Theophylline | 1994 |
High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. V. Validation of a direct injection/on-line guard cartridge extraction--tandem mass spectrometry method for CYP1A2 inhibition assessment.
Topics: Benzoflavones; Biological Assay; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Enzyme Inhibitors; Humans; Mass Spectrometry; Microsomes, Liver; Oxazines; Theophylline | 2001 |